glp 1 agonist alcohol Repurposing GLP-1 receptor agonists for use disorder: a systematic review and meta-analysis | Diabetology & Metabolic Syndrome GLP-1 Therapeutics and Their Emerging

Xing D, Yoo C, Gonzalez D, Jenkins V, Nottingham K, Dickerson B et al (2021) Dose-response of Paraxanthine on cognitive function: a double blind, placebo controlled, crossover trial

Esta dosis favorece la disponibilidad de carnitina para el manejo de metabolitos acumulados durante el entrenamiento intenso, el mantenimiento del pool de CoA libre mitocondrial, y proporciona cierto soporte antioxidante mediante las propiedades protectoras de la L-Carnitina sobre las membranas mitocondriales

Isaac C-RJ, Ignacio V-F, Francisco G-LR, Fernando T-VJ, David P-MJ, Walfred R-F, Alberto G-IJ

Nuclear factor erythroid 2-related factor 2 as a treatment target of kidney diseases

Although the exact pathogenic mechanism of DKD is still unclear, programmed cell death has been demonstrated to participate in the occurrence and development of diabetic kidney injury, including ferroptosis